Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1140 | 1027 | 1201 | 1080 | 1569 | 2400 |
Fund Return | 14% | 2.74% | 20.06% | 2.59% | 9.43% | 9.15% |
Place in category | 1574 | 1055 | 1601 | 1049 | 823 | 336 |
% in Category | 57 | 40 | 58 | 46 | 48 | 38 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU0090841692 | 1.1B | 17.14 | 7.46 | 6.85 | ||
Global Allocation Fund X2 USD | 786.93M | 12.90 | 3.74 | 6.58 | ||
LU0724617625 | 1.27B | 11.16 | 1.98 | 4.77 | ||
BlackRock Glbl Funds Glbl Alloc E2 | 1.22B | 10.65 | 1.48 | 4.25 | ||
LU0147395726 | 355.35M | 9.88 | 0.71 | 3.47 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Cap Group New Perspective lux ZLgd | 15.86B | 18.28 | 3.62 | 10.80 | ||
Cap Group New Perspective lux N USD | 15.86B | 16.59 | 1.96 | - | ||
Capital Group New Perspective Fundu | 15.86B | 18.34 | 3.65 | 10.83 | ||
Capital Group New Perspective Funbu | 15.86B | 17.23 | 2.61 | 9.75 | ||
Capital Group New Perspective Funzu | 15.86B | 18.04 | 3.39 | 10.62 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 7.38 | 423.35 | +1.14% | |
Amazon.com | US0231351067 | 5.07 | 224.19 | +1.80% | |
Boston Scientific | US1011371077 | 4.43 | 90.69 | +1.47% | |
UnitedHealth | US91324P1021 | 4.32 | 513.00 | +1.68% | |
Applied Materials | US0382221051 | 4.27 | 170.06 | +3.78% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Neutral | Buy |
Technical Indicators | Strong Sell | Sell | Strong Buy |
Summary | Strong Sell | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review